What sources does Taxxa search?

Taxxa searches a continuously updated collection of more than one million pages from tax authorities, government publications, legislation and case law across the European jurisdictions it covers. Every response cites the underlying material, so a professional can inspect the rule, its jurisdiction and whether it is current before relying on the result.

Can Taxxa work with a team’s own documents?

Yes. Research can combine the public knowledge base with a team’s own PDF, DOCX, CSV and TXT files in one workspace. That makes it possible to compare a client document with the relevant guidance, trace a conclusion to its source and prepare a draft without losing the evidence that supports it.

Who is Taxxa built for?

Accountants, auditors, tax advisors, payroll specialists, bookkeepers and advisory teams working across European jurisdictions. Shared workspaces keep research available to colleagues, and citations make review easier.

Where is customer data stored, and is it used to train models?

Customer data stays in the European Union and is never used to train language models.

Does Taxxa replace professional judgement?

No. Taxxa is a research and drafting workspace. It helps professionals reach an informed starting point faster; the professional still reviews the evidence and makes the final decision. It does not file returns, post bookkeeping entries or give legal advice.

FranceLégifrance

Sanofi extends sick pay to 12 months at full salary

Avenant n°2 to the 2007 accord keeps full salary for 12 months of illness or accident leave and adds 12 months on the unworked share of therapeutic part-time; open-ended from 1 January 2024.

By Taxxa AI OyPublished 9 November 2026

Payroll & Labour

Employees of Sanofi's French companies who stop work through illness or accident keep their full salary for twelve monthsLegifrance, and employees who return on therapeutic part-time keep their salary on the unworked portion for twelve monthsLegifrance. Avenant n°2 to the group accord of 20 December 2007 on indemnisation de la maladie et de l'accident, concluded between all French companies of the Sanofi group and the unions CFDT, CFE-CGC, CFTC and CGT, rewrites article 2 on the duration of salary maintenance and adds a therapeutic part-time limb with its own twelve-month counterLegifrance.

For ordinary sick leave, the conditions are a medically justified illness or accident covered by the Sécurité sociale and one year's service in the company on the first day of absence. The employer then maintains salary at the full rate for the first twelve monthsLegifrance, after deducting Sécurité sociale daily allowances and any applicable daily provident benefits, both the Régime Professionnel Conventionnel and the Sanofi provident scheme. Maintenance can never exceed 100% of net income from work and is paid under the subrogation procedures in force in the company. While the maintained leave runs, the employee keeps accruing paid-leave rights.

For therapeutic part-time, the same architecture applies to the unworked share: the employee must be covered by the Sécurité sociale for the therapeutic part-time, receive Sécurité sociale daily allowances on that basis, and have one year's service on the first day of Sécurité sociale coverage under the therapeutic part-time. The employer maintains salary on the non-worked portion for the first twelve months of the therapeutic part-timeLegifrance, again net of Sécurité sociale and provident daily allowances, capped at 100% of net income from work and paid under the company's subrogation procedures. The twelve-month counter for ordinary leave and the twelve-month counter for therapeutic part-time are two distinct counters, so one does not consume the other.Legifrance

The text presents the change as part of Sanofi's worldwide « Cancer & Travail — Agir ensemble » programme launched in France in 2024, aimed at letting employees reconcile serious illness with work, securing the finances of employees hit directly or indirectly by cancer or another serious illness or accident during leave, and encouraging a gradual return to work. The preamble frames the avenant as continuing the group's existing French bargaining commitments, improving compensation during leave and extending it to the gradual-return phase.

In time, the avenant runs for an indefinite periodLegifrance and its provisions take effect on 1 January 2024Legifrance. They cover every stoppage and every therapeutic part-time arrangement beginning on or after that dateLegifrance, and also stoppages and therapeutic part-time already under way before 1 January 2024 that continue without interruption beyond it, provided the previous nine-month salary-maintenance period had not yet been reached when the new rules arrivedLegifrance. Payroll teams therefore apply the twelve-month measure both prospectively and to qualifying ongoing casesLegifrance carried over from 2023.

The avenant will be notified to all representative unions in its scope, then filed on the Ministry of Labour's national TéléAccords platform and with the registry of the Paris Conseil de Prud'hommes, in line with articles L. 2231-5 and following and D. 2231-2 of the Code du travail. Legal basis: avenant n°2 à l'accord relatif à l'indemnisation de la maladie et de l'accident du 20 décembre 2007, articles L. 2231-5 et suivants et D. 2231-2 du Code du travail.

Apply twelve months of full salary maintenance to qualifying Sanofi sick leaves and to the unworked share of qualifying therapeutic part-time from 1 January 2024, keeping the two counters separate.

Sources

AVENANT N2 A L'ACCORD RELATIF A L'INDEMNISATION DE LA MALADIE ET DE L'ACCIDENT DU 20 DECEMBRE 2007